MENU

CTOR Citius Oncology Inc Forecast, Technical & Fundamental Analysis

Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies... Show more

CTOR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
CTOR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

CTOR is expected to report earnings to rise 216.67% to -18 cents per share on December 17

Citius Oncology Inc CTOR Stock Earnings Reports
Q3'26
Est.
$-0.19
Q4'25
Missed
by $0.04
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.01
Q1'25
Missed
by $0.05
The last earnings report on February 13 showed earnings per share of -5 cents, missing the estimate of -1 cents. With 3.11K shares outstanding, the current market capitalization sits at 78.66M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBIYX15.620.20
+1.30%
ClearBridge International Value I
BIAHX19.010.21
+1.12%
Brown Advisory WMC Strat Eurp Eq Inv
ALABX13.850.05
+0.36%
ALPS Balanced Opportunity A
AFGFX89.300.31
+0.35%
Virtus Silvant Focused Growth R6
MITJX36.520.12
+0.33%
MFS Massachusetts Investors Tr R6

CTOR and Stocks

Correlation & Price change

A.I.dvisor tells us that CTOR and PRGO have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTOR and PRGO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTOR
1D Price
Change %
CTOR100%
-2.02%
PRGO - CTOR
26%
Poorly correlated
+4.01%
BFRI - CTOR
25%
Poorly correlated
N/A
RDHL - CTOR
24%
Poorly correlated
+0.89%
CGC - CTOR
22%
Poorly correlated
N/A
ACB - CTOR
21%
Poorly correlated
+3.41%
More

Groups containing CTOR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTOR
1D Price
Change %
CTOR100%
-2.02%
Pharmaceuticals
category (157 stocks)
9%
Poorly correlated
+0.83%
Pharmaceuticals: Generic
category (84 stocks)
8%
Poorly correlated
+1.02%
Citius Oncology (CTOR) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com